- Home
- ICCT vs PTIX Comparison
ICCT vs PTIX Comparison
Compare ICCT & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCT
- PTIX
- Stock Information
- Founded
- ICCT 1992
- PTIX 1994
- Country
- ICCT United States
- PTIX United States
- Employees
- ICCT N/A
- PTIX N/A
- Industry
- ICCT Computer Software: Prepackaged Software
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- ICCT Technology
- PTIX Health Care
- Exchange
- ICCT Nasdaq
- PTIX Nasdaq
- Market Cap
- ICCT 4.1M
- PTIX 3.7M
- IPO Year
- ICCT N/A
- PTIX 2016
- Fundamental
- Price
- ICCT $0.19
- PTIX $0.70
- Analyst Decision
- ICCT
- PTIX
- Analyst Count
- ICCT 0
- PTIX 0
- Target Price
- ICCT N/A
- PTIX N/A
- AVG Volume (30 Days)
- ICCT 17.9M
- PTIX 258.9K
- Earning Date
- ICCT 11-19-2024
- PTIX 11-14-2024
- Dividend Yield
- ICCT N/A
- PTIX N/A
- EPS Growth
- ICCT N/A
- PTIX N/A
- EPS
- ICCT N/A
- PTIX N/A
- Revenue
- ICCT $11,049,477.00
- PTIX N/A
- Revenue This Year
- ICCT N/A
- PTIX N/A
- Revenue Next Year
- ICCT N/A
- PTIX N/A
- P/E Ratio
- ICCT N/A
- PTIX N/A
- Revenue Growth
- ICCT 42.66
- PTIX N/A
- 52 Week Low
- ICCT $0.15
- PTIX $0.45
- 52 Week High
- ICCT $2.31
- PTIX $1.87
- Technical
- Relative Strength Index (RSI)
- ICCT 41.62
- PTIX 55.96
- Support Level
- ICCT $0.15
- PTIX $0.50
- Resistance Level
- ICCT $0.34
- PTIX $0.56
- Average True Range (ATR)
- ICCT 0.03
- PTIX 0.06
- MACD
- ICCT 0.00
- PTIX 0.01
- Stochastic Oscillator
- ICCT 6.01
- PTIX 84.31
About ICCT iCoreConnect Inc. Common stock
iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.